Update on Management of Type 2 Diabetes for Cardiologists
Article Citation:
Qureshi M, Gammoh E, Shakil J, Robbins R. Update on Management of Type 2 Diabetes for Cardiologists. Methodist DeBakey Cardiovasc J. 2018;14(4):273-80.
doi:Abstract
The management of type 2 diabetes mellitus has evolved over the last several years as new antidiabetic agents continue to arrive and change the goals of diabetes care. In 2008, the U.S. Food and Drug Administration mandated that all new antidiabetic agents must demonstrate cardiovascular (CV) safety, which has led to a series of CV outcome trials. In this article, we review the key findings from these CV outcome trials and their impact on diabetes care guidelines.
Keywordstype 2 diabetes mellitus , diabetes management , cardiovascular outcome trials , cardiovascular safety , major adverse cardiac events
PRINTER-FRIENDLY VERSION
PDF DOWNLOAD
ADD TO FAVORITES
EXPORT CITATIONS
TRACK CITATION